Your Trusted Brand for Over 35 Years

Asthma References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Morris M (auth) and Mosenifar Z (ed). Asthma. Updated 2/12/2012. Available at: Accessed 4/10/2012.
  2. Vestergaard P, Rejnmark L, and Mosekilde L. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest. 2007 Nov;132(5):1599-607. Epub 2007 Sep 21.
  3. Pauwels RA, Yernault JC, Demedts MG, et al. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):827-32.
  4. Young C. Avoiding Asthma Triggers: A Primer for Patients. J Am Osteopath Assoc November 1, 2011 vol. 111 no. 11 suppl 7 S30-S32.
  5. Wang J, Visness CM, Sampson HA. Food allergen sensitization in inner-city children with asthma. J Allergy Clin Immunol. 2005 May;115(5):1076-80.
  6. Lee CH, Kim YS, Kang NI, et al. IgG immune complex induces the recruitment of inflammatory cells into the airway and TNF-mediated late airway hyperresponsiveness via NF-κB activation in mice. J Asthma. 2011 Oct;48(8):757-66. Epub 2011 Aug 22.
  7. Shakib F, Brown HM, Phelps A, et al. Study of IgG sub-class antibodies in patients with milk intolerance. Clin Allergy. 1986 Sep;16(5):451-8.
  8. Lemanske RF Jr, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S95-102.
  9. Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Altern Med Rev. 2001 Feb;6(1):20-47.
  10. James A. Airway remodeling in asthma. Curr Opin Pulm Med. 2005 Jan;11(1):1-6.
  11. Davies DE. The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc. 2009 Dec;6(8):678-82.
  12. Campbell AM. Bronchial epithelial cells in asthma. Allergy 1997: 52: 483-489, © Munksgaard 1997,
  13. Kaufman G. Asthma: pathophysiology, diagnosis and management. Nurs Stand. 2011 Oct 5-11;26(5):48-56.
  14. Wang J and Liu AH. Food allergies and asthma. Curr Opin Allergy Clin Immunol. 2011 Jun;11(3):249-54.
  15. Abramson MJ, Puy RM, and Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003; (4):CD001186 (ISSN: 1469-493X)
  16. Fujimura T, Okamoto Y, Taniguchi M. Therapeutic effects and biomarkers in sublingual immunotherapy: a review. J Allergy (Cairo). 2012;2012:381737. Epub 2012 Mar 5.
  17. Oehling A, Ona J, Trento H, et al. The diagnostic value of the histamine release test in food allergy. Allergol Immunopathol (Madr). 1984 Nov-Dec;12(6):439-48.
  18. Stapleton M, Howard-Thompson A, George C, Hoover RM, Self TH. Smoking and asthma. J Am Board Fam Med. 2011 May-Jun;24(3):313-22.
  19. PubMed Health. A.D.A.M. Medical Encyclopedia. Occupational asthma. Reviewed 5/2/2011. Available at Accessed: 4/23/2012.
  20. Bakerly ND, Moore VC, et al. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup Med (Lond). 2008 May;58(3):169-74.
  21. Vandenplas O. Occupational asthma: etiologies and risk factors. Allergy Asthma Immunol Res. 2011 Jul;3(3):157-67.
  22. Murk W, Risnes KR, Bracken MB. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics. 2011 Jun;127(6):1125-38. Epub 2011 May 23.
  23. Mannie MD. Autoimmunity and asthma: The dirt on the hygiene hypothesis. Self Nonself. 2010 Apr;1(2):123-128. Epub 2010 Feb 15.
  24. Sanfiorenzo C and Pipet A. [Exacerbations of asthma--precipitating factors: drugs]. Rev Mal Respir. 2011 Oct;28(8):1059-70. Epub 2011 Oct 1.
  25. Yonas MA, Lange NE, and Celedon JC. Psychosocial stress and asthma morbidity. Curr Opin Allergy Clin Immunol. 2012 Apr;12(2):202-10.
  26. Boulet LP, Boulay MÈ. Asthma-related comorbidities. Expert Rev Respir Med. 2011 Jun;5(3):377-93.
  27. Cazzola M, Calzetta L, et al. Asthma and comorbid medical illness. Eur Respir J. 2011 Jul;38(1):42-9.
  28. Pearce L. Understanding spirometry. Nurs Times. 2011 Oct 25-31;107(42):14, 16-7.
  29. Simons FE. Inhaled glucocorticoids in children: A favourable therapeutic index. Can Respir J. 1999;6(2):175-8.
  30. Wraight JM, Smith AD, et al. Adverse effects of short-acting beta-agonists: Potential impact when anti-inflammatory therapy is inadequate. Respirology. 2004 Jun;9(2):215–21.
  31. Ohta K, Yamaguchi M, Akiyama K, et al. Japanese guideline for adult asthma. Allergol Int. 2011 Mar;60(2):115-45.
  32. Spahn JD, Covar R, and Szefler SJ. Adkinson: Middleton's Allergy: Principles and Practice, 7th ed. Chapter 89 – Glucocorticoids: Clinical Pharmacology. Available at: Accessed 4/23/2012.
  33. Wood PR, Hill VL. Practical management of asthma. Pediatr Rev. 2009 Oct;30(10):375-85.
  34. Global Initiatives for Asthma (GINA). 2011.
  35. Kupczyk M, Dahlen B, Dahlen SE. Which anti-inflammatory drug should we use in asthma? Pol Arch Med Wewn. 2011;121(12):455-9.
  36. Merck Manual Home Health Handbook. Asthma. Accessed 4.16.2012
  37. Nagai H. Recent research and developmental strategy of anti-asthma drugs. armacol Ther. 2012 Jan;133(1):70-8. Epub 2011 Sep 6.
  38. Wada M, Nagata S, Kudo T, et al. Effect of suplatast tosilate on antileukotriene non-responders with mild-to-moderate persistent asthma. Allergol Int. 2009 Sep;58(3):389-93. Epub 2009 Jun 25.
  39. Stokes J and Casale TB. Rationale for new treatments aimed at IgE immunomodulation. Ann Allergy Asthma Immunol. 2004 Sep;93(3):212-7; quiz 217-9, 271.
  40. Shiga M, Horiguchi T, Kondo R, et al. Long-term monotherapy with suplatast tosilate in patients with mild atopic asthma: a pilot comparison with low-dose inhaled fluticasone. Asian Pac J Allergy Immunol. 2011 Jun;29(2):134-42.
  41. Tamaoki J, Kondo M, Sakai N, et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study outline goes here Lancet. 2000 Jul 22;356(9226):273-8.
  42. Sano T, Nakamura Y, Yanagawa H, et al. Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids. Lung. 2003;181(4):227-35.
  43. monograph. Suplaatast Tosilate. Available at: Accessed, 4/10/2012
  44. Davydov L. Omalizumab (Xolair) for treatment of asthma. Am Fam Physician. 2005 Jan 15;71(2):341-2.
  45. Walsh GM. Antagonism of eosinophil accumulation in asthma. Recent Pat Inflamm Allergy Drug Discov. 2010 Nov;4(3):210-3.
  46. Conroy DM and Williams TJ. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2001, 2:150–156
  47. Corren J. Anti-interleukin-5 antibody therapy in asthma and allergies. Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):565-70.
  48. Thomson NC, Chaudhuri R, et al. Emerging therapies for severe asthma. BMC Med. 2011 Sep 6;9:102.
  49. Haldar P, Brightling CE, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84.
  50. Nair P, Pizzichini MM, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93.
  51. Castro M, for the Res-5-0010 Study Group. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2011 Nov 15;184(10):1125-32.
  52. Piehler D, Stenzel W, Grahnert A, et al. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am J Pathol. 2011 Aug;179(2):733-44.
  53. Wenzel S, Wilbraham D, Fuller R, et al. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet. 2007 Oct 20;370(9596):1422-31.
  54. Gildea TR, Khatri SB, et al. Bronchial thermoplasty: a new treatment for severe refractory asthma. Cleve Clin J Med. 2011 Jul;78(7):477-85.
  55. National Heart, Lung and Blood Institute. The 2007 Guidelines for the Diagnosis and Management of Asthma. (
  56. Kosti RI, Priftis KN, et al. The Association between Leisure-Time Physical Activities and Asthma Symptoms among 10- to 12-Year-Old Children: The Effect of Living Environment in the PANACEA Study. J Asthma. 2012 Feb 2.
  57. Vempati R, Bijlani R, et al. The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: a randomized controlled trial.
  58. Mekonnen D and Mossie A. Clinical effects of yoga on asthmatic patients: a preliminary clinical trial. Ethiop J Health Sci. 2010 Jul;20(2):107-12.
  59. Littner MR, Leung FW, et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005;128(3):1128–35.
  60. Wright RJ. Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics. Immunol Allergy Clin North Am. 2011 Feb;31(1):19-39.
  61. Gilliland FD, Berhane KT, et al. Children's lung function and antioxidant vitamin, fruit, juice, and vegetable intake. Am J Epidemiol. 2003 Sep 15;158(6):576-84.
  62. Maniscalco M, Zedda A, et al. Weight loss and asthma control in severely obese asthmatic females. Respir Med. 2008 Jan;102(1):102-8.
  63. Chatzi L, Kogevinas M. Prenatal and childhood Mediterranean diet and the development of asthma and allergies in children. Public Health Nutr. Sep;12(9A):1629-34.
  64. Arvaniti F, Priftis KN, et al. Adherence to the Mediterranean type of diet is associated with lower prevalence of asthma symptoms, among 10-12 years old children: the PANACEA study. Pediatr Allergy Immunol. 2011 May;22(3):283-9. doi: 10.1111/j.1399-3038.2010.01113.x.
  65. Grigoropoulou D, Priftis KN, et al. Urban environment adherence to the Mediterranean diet and prevalence of asthma symptoms among 10- to 12-year-old children: The Physical Activity, Nutrition, and Allergies in Children Examined in Athens study. Allergy Asthma Proc. 2011 Sep-Oct;32(5):351-8.
  66. Barros R, Moreira A, et al. Adherence to the Mediterranean diet and fresh fruit intake are associated with improved asthma control. Allergy. 2008 Jul;63(7):917-23.
  67. Boyer J and Liu RH. Apple phytochemicals and their health benefits. Nutr J. 2004 May 12;3:5.
  68. Hyson DA. A comprehensive review of apples and apple components and their relationship to human health. Adv Nutr. 2011 Sep;2(5):408-20. Epub 2011 Sep 6.
  69. Taher YA, van Esch BC, et al. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol. 2008 Apr 15;180(8):5211-21.
  70. Damera G, Fogle H, et al. (2009) Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol 158, 1429–1441.
  71. Majak P, Olszowiec-Chlebna M, et al. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011 May;127(5):1294-6. Epub 2011 Feb 18.
  72. Chinellato I, Piazza M, et al. Vitamin D serum levels and markers of asthma control in Italian children. J Pediatr 2011;158:437–441.
  73. Sutherland ER, Goleva E, et al. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med 2010;181:699–704.
  74. Searing DA, Zhang Y, et al. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol 2010;125:995–1000.
  75. Devereux G, Litonjua AA, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007 Mar;85(3):853-9.
  76. Erkkola M, Kaila M, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009 Jun;39(6):875-82.
  77. Miyake Y, Sasaki S, et al. Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants. Eur Respir J. 2010 Jun;35(6):1228-34.
  78. Brehm JM, Schuemann B, et al. Childhood Asthma Management Program Research Group.Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010 Jul;126(1):52-8.e5.
  79. Hollams EM, Hart PH, et al. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur Respir J. 2011 Dec;38(6):1320-7.
  80. Li-Weber M, Giaisi M, et al. (2002) Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur J Immunol 32, 2401–2408.
  81. Litonjua AA. Fat-soluble vitamins and atopic disease: what is the evidence? Proc Nutr Soc. 2012 Feb;71(1):67-74.
  82. Miyake Y, Sasaki S, Tanaka K, et al. Consumption of vegetables, fruit, and antioxidants during pregnancy and wheeze and eczema in infants. Allergy. 2010 Jun 1;65(6):758-65.
  83. Litonjua AA, Rifas-Shiman SL, et al. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr 2006;84:903-11.
  84. Devereux G, Turner SW, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med 2006;174:499-507.
  85. Nurmatov U, Devereux G, et al. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J Allergy Clin Immunol. 2011 Mar;127(3):724-33.e1-30.
  86. Gao J, Gao X, et al. Observational studies on the effect of dietary antioxidants on asthma: a meta-analysis. Respirology. 2008 Jun;13(4):528-36.
  87. Jeong YJ, Kim JH, et al. Mega-dose vitamin C attenuated lung inflammation in mouse asthma model.Anat Cell Biol. 2010 Dec;43(4):294-302.
  88. Biltagi MA, Baset AA, et al. Omega-3 fatty acids, vitamin C and Zn supplementation in asthmatic children: a randomized self-controlled study. Acta Paediatr. 2009 Apr;98(4):737-42.
  89. Tecklenburg SL, Mickleborough TD, et al. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007 Aug;101(8):1770-8.
  90. Black PN, Sharpe S. Dietary fat and asthma: Is there a connection? Eur Respir J. 1997;10:6-12.
  91. Laerum BN, Wentzel-Larsen T, et al. Relationship of fish and cod oil intake with adult asthma. Clin Exp Allergy. 2007;37:1616-1623.
  92. Miyamoto S, Miyake Y, et al, Osaka Maternal and Child Health Study Group. Fat and fish intake and asthma in Japanese women: Baseline data from the Osaka Maternal and Child Health Study. Int J Tuberc Lung Dis. 2007;11:103-109.
  93. Nagel G, Linseisen J. Dietary intake of fatty acids, antioxidants and selected food groups and asthma in adults. Eur J Clin Nutr. 2005; 59:8-15.
  94. Mickleborough TD, Lindley MR, et al. Protective effect of fish oil supplementation. Chest. 2006;129:39-49.
  95. Schubert R, Kitz R, et al. Effect of n-3 polyunsaturated fatty acids in asthma after low dose allergen challenge. Int Arch Allergy Immunol. 2009;148:321-329.
  96. Feleszko W, Jaworska J, Rha RD, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy. 2007 Apr;37(4):498-505.
  97. Lomax AR and Calder PC. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des. 2009;15(13):1428-518.
  98. Vliagoftis H, Kouranos VD, Betsi GI, et al. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol. 2008 Dec;101(6):570-9.
  99. Chen YS, Jan RL, Lin YL, et al. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol. 2010 Nov;45(11):1111-20.
  100. Qujeq, D, Hidari B, et al. 2003. Glutathione peroxidase activity and serum selenium concentration in intrinsic asthmatic patients. Clin. Chem. Lab. Med. 41: 200-202.
  101. Allam MF, Lucane RA. Selenium supplementation for asthma. Cochrane Database Syst Rev. 2004;(2):CD003538.
  102. Rubin RN, Navon L, et al. Relationship of serum antioxidants to asthma prevalence in youth. Am J Respir Crit Care Med. 2004 Feb 1;169(3):393-8.
  103. Gazdik F, Horvathova M, Gazdikova K, et al. The influence of selenium supplementation on the immunity of corticoid-dependent asthmatics. Braisl Lek Listy. 2002;103(1):17-21.
  104. Voicekovska JG, Orlikov GA, Karpov IuG, et al. [External respiration function and quality of life in patients with bronchial asthma in correction of selenium deficiency]. [Article in Russian]. Ter Arhk. 2007;79(8):38-41.
  105. Shaheen SO, Newson RB, Rayman MP, et al. Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma. Thorax. 2007 Jun;62(6):483-90.
  106. Jayaram L, Chunilal S, et al. Sputum zinc concentration and clinical outcome in older asthmatics. Respirol. 2011;16:459–466. doi: 10.1111/j.1440-1843.2011.01932.x
  107. Morgan CI, Ledford JR, et al. Zinc supplementation alters airway inflammation and airway hyperresponsiveness to a common allergen. J Inflamm (Lond). 2011 Dec 7;8:36.
  108. Gourgoulianis KI, Chatziparasidis G, Chatziefthimiou A, et al. Magnesium as a relaxing factor of airway smooth muscles. J Aerosol Med. 2001 Fall;14(3):301-7.
  109. Kazaks AG, Uriu-Adams JY, et al. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. J Asthma. 2010 Feb;47(1):83-92.
  110. Bede O, Suranyi A, et al. Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: A randomized, placebo-controlled, double-blind study. Magnes Res. 2003 Dec;16(4):262–70.
  111. Gontijo-Amaral C, Ribeiro M, et al. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial. Eur J Clin Nutr. 2007 Jan;61(1):54-60.
  112. Song WJ, Chang YS. Magnesium sulfate for acute asthma in adults: a systematic literature review. Asia Pac Allergy. 2012 Jan;2(1):76-85.
  113. Oh SW, Cha JY, et al. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition. J Ethnopharmacol. 2011 Jul 14;136(3):414-21.
  114. Neuman I, Nahum H, et al. Reduction of exercise-induced asthma oxidative stress by lycopene, a natural antioxidant. Allergy. 2000 Dec;55(12):1184–9.
  115. Hazlewood L, Wood L, et al. Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma. J Nutr Biochem. 2011 Jan;22(1):95-100. Epub 2010 Apr 13.
  116. Lee CM, Chang JH, et al. Lycopene suppresses ovalbumin-induced airway inflammation in a murine model of asthma. Biochem Biophys Res Commun. 2008 Sep 19;374(2):248-52.
  117. Garcia V, Arts IC, et al. Dietary intake of flavonoids and asthma in adults. Eur Respir J. 2005 Sep;26(3):449-52.
  118. Weng Z, Zhang B, Asadi S, et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans. PLoS One. 2012;7(3):e33805. Epub 2012 Mar 28.
  119. Knekt P, Kumpulainen J, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002 Sep;76(3):560–8.
  120. Joskova M, Franova S, et al. Acute bronchodilator effect of quercetin in experimental allergic asthma. Bratisl Lek Listy. 2011;112(1):9-12.
  121. Rogerio AP, Dora CL, et al. Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. Pharmacol Res. 2010 Apr;61(4):288-97.
  122. Park HJ, Lee CM, et al. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int Immunopharmacol. 2009 Mar;9(3):261-7.
  123. Cos P, de Bruyne T, et al. Proanthocyanidins in health care: current and new trends. Current Medicinal Chemistry 2004;11(10): 1345–59.
  124. Lau BH, Riesen SK, et al. Pycnogenol as an adjunct in the management of childhood asthma. J Asthma. 2004;41(8):825-32.
  125. Belcaro G, Luzzi R, et al. Pycnogenol® improvements in asthma management. Panminerva Med. 2011 Sep;53(3 Suppl 1):57-64.
  126. Mahmoud F, Abul H, et al. In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: Comparison with cyclosporin A. Jpn J Pharmacol. 2000 Jul;83(3):241–5.
  127. Li MH, Zhang HL, et al. [Effects of ginkgo leave concentrated oral liquor in treating asthma]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Apr;17(4):216–8.
  128. Tang Y, Xu Y, et al. The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients. J Huazhong Univ Sci Technolog Med Sci. 2007 Aug;27(4):375-80.
  129. Chu X, Ci X, et al. A novel anti-inflammatory role for ginkgolide B in asthma via inhibition of the ERK/MAPK signaling pathway. Molecules. 2011 Sep 6;16(9):7634-48.
  130. Thomet OA, Simon HU. Petasins in the treatment of allergic diseases: results of preclinical and clinical studies. Int Arch Allergy Immunol. 2002 Oct;129(2):108-12.
  131. Danesch UC. Petasites hybridus (Butterbur root) extract in the treatment of asthma--an open trial. Altern Med Rev. 2004 Mar;9(1):54-62.
  132. Lee DK, Haggart K, Robb FM, et al. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin Exp Allergy. 2004 Jan;34(1):110-4.
  133. Shih CH, Huang TJ, et al. S-Petasin, the Main Sesquiterpene of Petasites formosanus, Inhibits Phosphodiesterase Activity and Suppresses Ovalbumin-induced Airway Hyperresponsiveness. Evid Based Complement Alternat Med. 2009 Jul 29.
  134. Brattström A, Schapowal A, et al. Petasites extract Ze 339 (PET) inhibits allergen-induced Th2 responses, airway inflammation and airway hyperreactivity in mice. Phytother Res. 2010 May;24(5):680-5.
  135. Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011 May;73(3):255-61.
  136. Abdel-Tawab M, Werz O, and Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011 Jun;50(6):349-69.
  137. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998 Nov 17;3(11):511-4.
  138. Houssen ME, Ragab A, Mesbah A, et al. Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthma. Clin Biochem. 2010 Jul;43(10-11):887-90. Epub 2010 Apr 27.
  139. Shivpuri DN, Menon MP, and Prakash D. A crossover double-blind study on Tylophora indica in the treatment of asthma and allergic rhinitis. J Allergy. 1969 Mar;43(3):145-50.
  140. Shivpuri DN, Singhal SC, and Parkash D. Treatment of asthma with an alcoholic extract of tylophora indica: a cross-over, double-blind study. Ann Allergy. 1972 Jul;30(7):407-12.
  141. Mathew KK, and Shipvuri DN. Treatment of asthma with alkaloids of tylophora indica: double blind study Aspects of Allergy & Applied Immunology 1974; 7:166-78.
  142. Clark CE, Arnold E, Lasserson TJ, et al. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Respir J. 2010 Dec;19(4):307-14.